← Back to Search
A Composite CMV-IE Enhancer/beta-actin Promoter Is Ubiquitously Expressed In Mouse Cutaneous Epithelium.
J. Sawicki, R. Morris, B. Monks, K. Sakai, J. Miyazaki
Published 1998 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
In most existing transgenic mouse models developed for the study of specific genes in the skin, the goal has been to target transgene expression to defined populations of cells in the cutaneous epithelium. Keratin promoters have been especially useful for this purpose. In some instances, however, it may be desirable to express a transgene in all the cells of the cutaneous epithelium. Since no ubiquitously expressed promoter sequences had previously been identified, we used lacZ reporter transgenes to test two enhancer/promoter sequences for ubiquitous expression in the skin of adult transgenic mice. We find that a CMV enhancer/CMV promoter is not active in most cell types in the skin, whereas a CMV enhancer/modified beta-actin promoter sequence is active in the suprabasal and basal cells of the epidermis as well as in the epithelial cells of the hair follicles, sebaceous glands, and the dermal papillae.
This paper references
The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.
P. Furth (1991)
The cytomegalovirus enhancer: a pan-active control element in transgenic mice.
E. Schmidt (1990)
Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.
J. Brocard (1997)
Powerful and versatile enhancer-promoter unit for mammalian expression vectors.
M. K. Foecking (1986)
Cell-specific ecdysone-inducible expression of FLP recombinase in mammalian cells.
J. Sawicki (1998)
8 – Transgenic Mouse Models for the Study of the Skin
C. Cavard (1993)
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
M. Boshart (1985)
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
H. Niwa (1991)
Green fluorescent protein as a marker in transgenic mice
M. Ikawa (1995)
Molecular Biology of The Skin
S. Arase (1977)
Site-specific recombinases: tools for genome engineering.
N. J. Kilby (1993)
Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP.
H. H. Niller (1990)
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Niwa Hitoshi (1991)
This paper is referenced by
A Systematic Survey and Characterization of Enhancers that Regulate Sox3 in Neuro-Sensory Development in Comparison with Sox2 Enhancers
Naoko Nishimura (2012)
A Transgenic Prox1-Cre-tdTomato Reporter Mouse for Lymphatic Vessel Research
Roberta Bianchi (2015)
Nrf2 links epidermal barrier function with antioxidant defense
M. Schaefer (2012)
Improving the immunogenicity of recombinant adeno-associated virus
James Edgeworth Ussher (2010)
Addressing the Role of Mitochondrial Thioredoxin Reductase and xCT in the Maintenance of Redox Homeostasis
Tamara Perisic (2010)
Immunization of olive flounder (Paralichthys olivaceus) with an auxotrophic Edwardsiella tarda mutant harboring the VHSV DNA vaccine.
S. Choi (2012)
A method for rapid gain-of-function studies in the mouse embryonic nervoussystem
N. Gaiano (1999)
Development of a novel Borna disease virus reverse genetics system using RNA polymerase II promoter and SV40 nuclear import signal.
H. Yanai (2006)
Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice
L. Ruan (2014)
pEPI for Gene Therapy Non viral episomes and their Application in Somatic Gene Therapy
Claudia Hagedorn (2013)
Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter.
Masayuki Endo (2008)
Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors
M. Allocca (2007)
Gene therapy for retinal disease.
M. McClements (2013)
An improved method for infectious bursal disease virus rescue using RNA polymerase II system.
X. Qi (2007)
Improved neuronal transgene expression from an AAV‐2 vector with a hybrid CMV enhancer/PDGF‐β promoter
C. Wang (2005)
Efficient ectopic gene expression targeting chick mesoderm
K. Oberg (2002)
RNAi Mouse Models of Breast Cancer Tumor Suppressor Genes
Saya H. Ebbesen (2013)
Development of AAV-mediated gene therapy for autosomal recessive bestrophinopathy
S. Wood (2017)
Analysis of ubiquitination in vivo using a transgenic mouse model.
M. Tsirigotis (2001)
Differential fates of biomolecules delivered to target cells via extracellular vesicles
Masamitsu Kanada (2015)
Spermine Synthesis Is Required for Normal Viability, Growth, and Fertility in the Mouse*
X. Wang (2004)
Applying a “Double‐Feature” Promoter to Identify Cardiomyocytes Differentiated from Human Embryonic Stem Cells Following Transposon‐Based Gene Delivery
T. Orbán (2009)
Human Lactate Dehydrogenase A (Ldha) Rescues Mouse Ldhc Null Sperm Function Running Title: Ldha RESCUES Ldhc NULL SPERM
Huanghui Tang (2013)
Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
T. M. Buck (2020)
siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model
E. González-González (2009)
Use of (Gyro) Gy and spermine synthase transgenic mice to study functions of spermine.
X. Wang (2011)
In vitro search for alternative promoters to the human immediate early cytomegalovirus (IE-cMV) to express the G gene of viral haemorrhagic septicemia virus (VHSV) in fish epithelial cells.
S. Ruiz (2008)
Optimization of transcriptional regulatory elements for constructing plasmid vectors.
Z. Xu (2001)
Predominant transgene expression in exocrine pancreas directed by the CMV promoter.
Y. Zhan (2000)
Improving transcriptional activity of human cytomegalovirus major immediate-early promoter by mutating NF-κB binding sites.
D. Wang (2018)
Understanding molecular mechanisms of breast cancer metastasis using genetically-engineered mice
L. Cook (2011)
Adeno-associated virus-vectored gene therapy for retinal disease.
A. Dinculescu (2005)See more